Inicio > Endocrinología y Nutrición > Efectos beneficiosos del café en el metabolismo lipídico > Página 5

Efectos beneficiosos del café en el metabolismo lipídico

high-fat diets. J Agric Food Chem 2009; 57: 11100–5.

18. Panchal SK, Poudyal H, Waanders J, Brown L. Coffee extract attenuates changes in cardiovascular and hepatic structure and function without decreasing obesity in high-carbohydrate, high-fat diet-fed male rats. J Nutr 2012; 142: 690–7.

19. Abrahao SA, Pereira RG, de Sousa RV. Influence of coffee brew in metabolic syndrome and type 2 diabetes. Plant Foods Hum Nutr 2013; 68: 184–9.

20. Yamauchi R, Kobayashi M, Matsuda Y. Coffee and caffeine ameliorate hyperglycemia, fatty liver, and inflammatory adipocytokine expression in spontaneously diabetic KK-Ay mice. J Agric Food Chem 2010; 58: 5597–603.

21. Murase T, Misawa K, Minegishi Y. Coffee polyphenols suppress dietinduced body fat accumulation by downregulating SREBP-1c and related molecules in C57BL/6J mice. Am J Physiol Endocrinol Metab 2011; 300: E122–33.

22. Vitaglione P, Morisco F, Mazzone G. Coffee reduces liver damage in a rat model of steatohepatitis: the underlying mechanisms and the role of polyphenols and melanoidins. Hepatology 2010; 52: 1652–61.

23. Matsuda Y, Kobayashi M, Yamauchi R. Coffee and caffeine improve insulin sensitivity and glucose tolerance in C57BL/6J mice fed a high-fat diet. Biosci Biotechnol Biochem 2011; 75: 2309–15.

24. Choi EY, Cho YO. Interaction of physical trainings and coffee intakes in fuel utilization during exercise in rats. Nutr Res Pract 2013; 7: 178–84.

25. Hino A, Adachi H, Enomoto M. Habitual coffee but not green tea consumption is inversely associated with metabolic syndrome: an epidemiological study in a general Japanese population. Diabetes Res Clin Pract 2007; 76: 383–9.

26. Driessen MT, Koppes LL, Veldhuis L, Samoocha D, Twisk JW. Coffee consumption is not related to the metabolic syndrome at the age of 36 years: the Amsterdam Growth and Health Longitudinal Study. Eur J Clin Nutr 2009; 63: 536–42.

27. Balk L, Hoekstra T, Twisk J. Relationship between long-term coffee consumption and components of the metabolic syndrome: the Amsterdam Growth and Health Longitudinal Study. Eur J Epidemiol 2009; 24: 203–9.

28. Matsuura H, Mure K, Nishio N. Relationship between coffee consumption and prevalence of metabolic syndrome among Japanese civil servants. J Epidemiol 2012; 22: 160–6.

29. Takami H, Nakamoto M, Uemura H. Inverse correlation between coffee consumption and prevalence of metabolic syndrome: baseline survey of the Japan Multi-Institutional Collaborative Cohort (J-MICC) Study in Tokushima, Japan. J Epidemiol 2013; 23: 12–20.

30. Mure K, Maeda S, Mukoubayashi C. Habitual coffee consumption inversely associated with metabolic syndrome-related biomarkers involving adiponectin. Nutrition 2013; 29: 982–7.

31. Catalano D, Martines GF, Tonzuso A. Protective role of coffee in nonalcoholic fatty liver disease (NAFLD). Dig Dis Sci 2010; 55: 3200–6.

32. Anty R, Marjoux S, Iannelli A. Regular coffee but not espresso drinking is protective against fibrosis in a cohort mainly composed of morbidly obese European women with NAFLD undergoing bariatric surgery. J Hepatol 2012; 57: 1090–6.

33. Molloy JW, Calcagno CJ, Williams CD. Association of coffee and caffeine consumption with fatty liver disease, nonalcoholic steatohepatitis, and degree of hepatic fibrosis. Hepatology 2012; 55: 429–36.

34. Guterrez-Grobe Y, Chavez-Tapia N, Sanchez-Valle V. High coffee intake is associated with lower grade nonalcoholic fatty liver disease: the role of peripheral antioxidant activity. Ann Hepatol 2012; 11: 350–5.

35. Birerdinc A, Stepanova M, Pawloski L, Younossi ZM. Caffeine is protective in patients with non-alcoholic fatty liver disease. Aliment Pharmacol Ther 2012; 35: 76–82.

36. Matsuzawa Y. Metabolic syndrome definition and diagnostic criteria in Japan. J Atheroscler Thromb 2005; 12: 301.

37. Grundy SM, Brewer HB Jr, Cleeman JI. Definition of metabolic syndrome: report of the National Heart, Lung, and Blood Institute/American Heart Association conference on scientific issues related to definition. Circulation 2004; 109: 433–8.

38. Ucar F, Sezer S, Erdogan S. The relationship between oxidative stress and nonalcoholic fatty liver disease: its effects on the development of nonalcoholic steatohepatitis. Redox Rep 2013; 18: 127– 33.

39. Rolo AP, Teodoro JS, Palmeira CM. Role of oxidative stress in the pathogenesis of nonalcoholic steatohepatitis. Free Radic Biol Med 2012; 52: 59–69.

40. Andersen LF, Jacobs DR Jr, Carlsen MH, Blomhoff R. Consumption of coffee is associated with reduced risk of death attributed to inflammatory and cardiovascular diseases in the Iowa Women’s Health Study. Am J Clin Nutr 2006; 83: 1039–46.

41. Shim SG, Jun DW, Kim EK. Caffeine attenuates liver fibrosis via defective adhesion of hepatic stellate cells in cirrhotic model. J Gastroenterol Hepatol 2013; doi: 10.1111/jgh.12317 [Epub ahead of print].

42. Arauz J, Moreno MG, Cort_es-Reynosa P, Salazar EP, Muriel P. Coffee attenuates fibrosis by decreasing the expression of TGF-b and CTGF in a murine model of liver damage. J Appl Toxicol 2012; 33: 970–9.

43. Ruhl CE, Everhart JE. Coffee and caffeine consumption reduce the risk of elevated serum alanine aminotransferase activity in the United States. Gastroenterology 2005; 128: 24–32.

44. Honjo S, Kono S, Coleman MP. Coffee consumption and serum aminotransferases in middle-aged Japanese men. J Clin Epidemiol 2001; 54: 823–9.

45. Grimes DA, Schulz KF. Bias and causal associations in observational research. Lancet 2002; 359: 248–52.